We won't get coronavirus vaccine results in October

Hello,

Today in healthcare news: The door has closed on getting vaccine data in October, and Eli Lilly ends its antibody trial in hospitalized COVID-19 patients — while the US is paying $375 million for 300,000 vials of the investigational drug.

Plus: A timeline of Trump's coronavirus statements matched with new cases over the course of the pandemic.

Pfizer's CEO repeatedly talked up getting coronavirus vaccine data in October. Now, he's asking for patience.

• Pfizer CEO Albert Bourla effectively closed the door Tuesday on knowing whether or not its experimental coronavirus vaccine would work by the end of October.
• On the New York pharma giant's third quarter earnings call, Bourla acknowledged the company has not yet started the first interim analysis for this final study, called a phase-three trial.
• In September, Bourla set public expectations for an October data readout, a timeline at odds with top government scientists like Dr. Anthony Fauci and Moncef Slaoui, Operation Warp Speed's chief scientist.
• Instead, Bourla asked on Tuesday for patience, as the study progresses.

Read the full story from Andrew Dunn here>>

Eli Lilly has ended a major COVID-19 antibody test among hospitalized patients

• Pharmaceutical company Eli Lilly announced Monday it would stop trials testing an antibody drug in hospitalized patients after data suggested treatment was "unlikely" to help this group recover from COVID-19.
• Eli Lilly had paused trials of the treatment in mid October after an independent board of experts raised health concerns.
• The company said trials including patients with milder forms of COVID-19 would continue.

Read the full story from Allana Akhtar here>>

A timeline of Trump's statements about the coronavirus juxtaposed with new cases throughout the pandemic

• President Donald Trump has made contradictory and false statements about the coronavirus pandemic since January.
• The chart below provides a timeline of some of Trump's statements juxtaposed with rates of new daily COVID-19 cases in the US.

See the full chart from Susie Neilson and Yuqing Liu here>>

More stories we're reading:

• A Yale scientist has written the first great book on how coronavirus is changing our lives — and he says 'normality' isn't coming back until 2024 (Business Insider)
• Researchers are starting to get an idea of what cognitive damage COVID-19 might cause (Reuters)
• WATCH: Dentists debunk 14 teeth myths (Business Insider)
• Livongo's CEO and president are leaving after the Teladoc merger is completed (MedCity News)

- Lydia